Abstract
Viruses can escape from host recognition by degradation of RIG-I or interference with the RIG-I signalling to establish persistent infections. However, the mechanisms by which host cells stabilize RIG-I protein for avoiding its degradation are largely unknown. We report here that, upon virus infection, the E3 ubiquitin ligase FBXW7 translocates from the nucleus into the cytoplasm and stabilizes RIG-I. FBXW7 interacts with SHP2 and mediates the degradation and ubiquitination of SHP2, thus disrupting the SHP2/c-Cbl complex, which mediates RIG-I degradation. When infected with VSV or influenza A virus, FBXW7 conditional knockout mice ($Lysm^+FBXW7^{f/f}$) show impaired antiviral immunity. FBXW7-deficient macrophages have decreased RIG-I protein levels and type-I interferon signalling. Furthermore, PBMCs from RSV-infected children have reduced FBXW7 mRNA levels. Our results identify FBXW7 as an important interacting partner for RIG-I. These findings provide insights into the function of FBXW7 in antiviral immunity and its related clinical significance.
Introduction: Protecting the Viral Alarm System
When a virus enters a cell, the host relies on pattern-recognition receptors like RIG-I to detect viral RNA and trigger the production of Type-I Interferons (IFNs)—the body’s primary antiviral defense. However, viruses have evolved clever ways to escape detection, often by hijacking the cell's own machinery to degrade RIG-I. While scientists previously understood how RIG-I is targeted for degradation via the SHP2/c-Cbl complex, a major question remained: how does the host cell stabilize RIG-I to prevent its premature degradation during an active infection? This research identifies the E3 ubiquitin ligase FBXW7 as the critical guardian that keeps this alarm system online when it is needed most.
The Mechanism: A Double-Negative Regulatory Loop
FBXW7 is an E3 ligase, an enzyme that typically marks proteins for destruction. Counterintuitively, FBXW7 stabilizes the antiviral response through a "double-negative" logic. It targets and degrades SHP2, a protein that normally facilitates the destruction of RIG-I. By removing SHP2, FBXW7 prevents the formation of the SHP2/c-Cbl complex, thereby shielding RIG-I from degradation.
This protection program is strategically regulated by spatial translocation. In resting cells, FBXW7 resides in the nucleus. Upon infection with an RNA virus, it translocates to the cytoplasm to interact with its targets. This ensures that the RIG-I stabilization mechanism is only activated during a genuine viral emergency.
Experimental Findings: FBXW7 is Essential for Survival
To test the importance of FBXW7, researchers generated conditional knockout mice ($Lysm^+ FBXW7^{f/f}$) lacking the protein in myeloid cells. These mice were significantly more susceptible to viral lethality; in a Vesicular Stomatitis Virus (VSV) model, nearly all knockout mice succumbed within 48 hours, whereas 50% of wild-type mice survived.
As shown in the data above, macrophages lacking FBXW7 produced significantly lower levels of critical antiviral cytokines, including IFN-β and IL-6. This deficit in the innate immune response allowed for much higher viral replication across multiple organs, including the lungs and spleen.
Clinical Relevance in Respiratory Infections
The study also explored the role of FBXW7 in human disease, specifically Respiratory Syncytial Virus (RSV). Analysis of peripheral blood mononuclear cells (PBMCs) from 70 infected children revealed that those with lower FBXW7 mRNA levels suffered from more severe clinical symptoms.
In vitro experiments confirmed this relationship: silencing FBXW7 led to a rapid and substantial increase in viral load (RSV-G mRNA) following infection, highlighting FBXW7's role as a potent restrictor of viral replication.
Conclusion and Future Directions
These findings establish FBXW7 as a key regulator of the RIG-I pathway specifically for RNA viruses. While the study focused on myeloid cells, future research is needed to determine if FBXW7 plays a similar protective role in epithelial cells, which are the primary targets for many respiratory viruses. Additionally, while FBXW7 presents a potential therapeutic target for boosting antiviral immunity, its role as a tumor suppressor means any intervention must be carefully designed to avoid disrupting cell cycle regulation.
Summary updated